Loading…
Tissue‐Selective Effects of Injected Deoxycholate
BACKGROUND Recent studies suggest that the principal active ingredient in phosphatidylcholine‐containing injectable fat‐reduction formulations is actually deoxycholate (DC). This bile acid acts as a detergent to rapidly disrupt cell membranes. Thus, it is not obvious why DC would preferentially targ...
Saved in:
Published in: | Dermatologic surgery 2010-06, Vol.36 (6), p.899-908 |
---|---|
Main Authors: | , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c3986-e2ae541a3538f22093dcd6cd0fbdbab585d63aca6ef45d540fbd5091745830383 |
---|---|
cites | cdi_FETCH-LOGICAL-c3986-e2ae541a3538f22093dcd6cd0fbdbab585d63aca6ef45d540fbd5091745830383 |
container_end_page | 908 |
container_issue | 6 |
container_start_page | 899 |
container_title | Dermatologic surgery |
container_volume | 36 |
creator | THUANGTONG, RATTAPON BENTOW, JASON J. KNOPP, KRISTEENE MAHMOOD, NADIR A. DAVID, NATHANIEL E. KOLODNEY, MICHAEL S. |
description | BACKGROUND
Recent studies suggest that the principal active ingredient in phosphatidylcholine‐containing injectable fat‐reduction formulations is actually deoxycholate (DC). This bile acid acts as a detergent to rapidly disrupt cell membranes. Thus, it is not obvious why DC would preferentially target fat.
OBJECTIVE
To investigate possible mechanisms for the selectivity of DC for fat tissue using in vivo and in vitro models.
METHODS AND MATERIALS Histology, drug distribution studies, and cell viability assays were used to examine possible mechanisms contributing to DC selectivity.
RESULTS In vitro, DC caused the lysis of all cell types tested within the tested concentration range. DC injected into fat tissue caused adipocyte death, whereas other cell types appeared less affected. Physiological concentrations of albumin or protein‐rich tissues decrease the ability of DC to lyse cells. Furthermore, DC relocated to the gastrointestinal tract in animals within hours of injection. This suggests that similar mechanisms may be present in humans.
CONCLUSION We report observations that provide a possible explanation for the in vivo preferential fat targeting by DC. Fat tissue, being deficient in cell‐associated proteins and interstitial albumin, may be unable to sufficiently neutralize the detergent activity of DC, possibly making fat uniquely sensitive to DC.
This study was funded by a grant from Kythera. Drs. Bentow and Knopp are consultants for Kythera, and Nadir Mahmood and Nathaniel David are employees of Kythera. |
doi_str_mv | 10.1111/j.1524-4725.2010.01566.x |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_733962015</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>733962015</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3986-e2ae541a3538f22093dcd6cd0fbdbab585d63aca6ef45d540fbd5091745830383</originalsourceid><addsrcrecordid>eNqNkE9PwjAYhxujEUS_gtnFeBr2z9ptBw8GUElIPADnpmvfxi2D4coUbn4EP6OfxA4Qr_bSX94-79v2QSgguE_8uiv6hNMojGLK-xT7KiZciP7mBHWPB6c-41iEmBPaQRfOFRgTmjJ8jjoURwmNKesiNsuda-D782sKJeh1_g7ByFqfXFDZYLwsfAQTDKHabPVrVao1XKIzq0oHV4e9h-aPo9ngOZy8PI0HD5NQszQRIVAFPCKKcZZYSnHKjDZCG2wzk6mMJ9wIprQSYCNueNTWOU5JHPGEYZawHrrdz13V1VsDbi0XudNQlmoJVeNkzFgq_Pe5J5M9qevKuRqsXNX5QtVbSbBsjclCtmJkK0a2xuTOmNz41uvDJU22AHNs_FXkgZsDoJxWpa3VUufuj6MpJtGOu99zH3kJ238_QA6n8zaxH2rHhnQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733962015</pqid></control><display><type>article</type><title>Tissue‐Selective Effects of Injected Deoxycholate</title><source>Wiley Online Library (Online service)</source><creator>THUANGTONG, RATTAPON ; BENTOW, JASON J. ; KNOPP, KRISTEENE ; MAHMOOD, NADIR A. ; DAVID, NATHANIEL E. ; KOLODNEY, MICHAEL S.</creator><creatorcontrib>THUANGTONG, RATTAPON ; BENTOW, JASON J. ; KNOPP, KRISTEENE ; MAHMOOD, NADIR A. ; DAVID, NATHANIEL E. ; KOLODNEY, MICHAEL S.</creatorcontrib><description>BACKGROUND
Recent studies suggest that the principal active ingredient in phosphatidylcholine‐containing injectable fat‐reduction formulations is actually deoxycholate (DC). This bile acid acts as a detergent to rapidly disrupt cell membranes. Thus, it is not obvious why DC would preferentially target fat.
OBJECTIVE
To investigate possible mechanisms for the selectivity of DC for fat tissue using in vivo and in vitro models.
METHODS AND MATERIALS Histology, drug distribution studies, and cell viability assays were used to examine possible mechanisms contributing to DC selectivity.
RESULTS In vitro, DC caused the lysis of all cell types tested within the tested concentration range. DC injected into fat tissue caused adipocyte death, whereas other cell types appeared less affected. Physiological concentrations of albumin or protein‐rich tissues decrease the ability of DC to lyse cells. Furthermore, DC relocated to the gastrointestinal tract in animals within hours of injection. This suggests that similar mechanisms may be present in humans.
CONCLUSION We report observations that provide a possible explanation for the in vivo preferential fat targeting by DC. Fat tissue, being deficient in cell‐associated proteins and interstitial albumin, may be unable to sufficiently neutralize the detergent activity of DC, possibly making fat uniquely sensitive to DC.
This study was funded by a grant from Kythera. Drs. Bentow and Knopp are consultants for Kythera, and Nadir Mahmood and Nathaniel David are employees of Kythera.</description><identifier>ISSN: 1076-0512</identifier><identifier>EISSN: 1524-4725</identifier><identifier>DOI: 10.1111/j.1524-4725.2010.01566.x</identifier><identifier>PMID: 20482723</identifier><language>eng</language><publisher>Malden, USA: Blackwell Publishing Inc</publisher><subject>Adipocytes - drug effects ; Animals ; Biological and medical sciences ; Cell Culture Techniques ; Cholagogues and Choleretics - administration & dosage ; Cholagogues and Choleretics - pharmacology ; Deoxycholic Acid - administration & dosage ; Deoxycholic Acid - pharmacology ; Dermatology ; Fibroblasts - drug effects ; Humans ; Injections, Subcutaneous ; Keratinocytes - drug effects ; Medical sciences ; Mice ; Mice, Obese ; Models, Animal ; Muscle Cells - drug effects ; Muscle, Skeletal - drug effects ; Muscle, Skeletal - metabolism ; Muscle, Skeletal - pathology ; Skin - drug effects ; Skin - metabolism ; Skin - pathology ; Skin plastic surgery ; Subcutaneous Fat - drug effects ; Subcutaneous Fat - metabolism ; Subcutaneous Fat - pathology ; Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><ispartof>Dermatologic surgery, 2010-06, Vol.36 (6), p.899-908</ispartof><rights>2010 by the American Society for Dermatologic Surgery, Inc.</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3986-e2ae541a3538f22093dcd6cd0fbdbab585d63aca6ef45d540fbd5091745830383</citedby><cites>FETCH-LOGICAL-c3986-e2ae541a3538f22093dcd6cd0fbdbab585d63aca6ef45d540fbd5091745830383</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1524-4725.2010.01566.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1524-4725.2010.01566.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,777,781,1412,27905,27906,45555,45556</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=22901423$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20482723$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>THUANGTONG, RATTAPON</creatorcontrib><creatorcontrib>BENTOW, JASON J.</creatorcontrib><creatorcontrib>KNOPP, KRISTEENE</creatorcontrib><creatorcontrib>MAHMOOD, NADIR A.</creatorcontrib><creatorcontrib>DAVID, NATHANIEL E.</creatorcontrib><creatorcontrib>KOLODNEY, MICHAEL S.</creatorcontrib><title>Tissue‐Selective Effects of Injected Deoxycholate</title><title>Dermatologic surgery</title><addtitle>Dermatol Surg</addtitle><description>BACKGROUND
Recent studies suggest that the principal active ingredient in phosphatidylcholine‐containing injectable fat‐reduction formulations is actually deoxycholate (DC). This bile acid acts as a detergent to rapidly disrupt cell membranes. Thus, it is not obvious why DC would preferentially target fat.
OBJECTIVE
To investigate possible mechanisms for the selectivity of DC for fat tissue using in vivo and in vitro models.
METHODS AND MATERIALS Histology, drug distribution studies, and cell viability assays were used to examine possible mechanisms contributing to DC selectivity.
RESULTS In vitro, DC caused the lysis of all cell types tested within the tested concentration range. DC injected into fat tissue caused adipocyte death, whereas other cell types appeared less affected. Physiological concentrations of albumin or protein‐rich tissues decrease the ability of DC to lyse cells. Furthermore, DC relocated to the gastrointestinal tract in animals within hours of injection. This suggests that similar mechanisms may be present in humans.
CONCLUSION We report observations that provide a possible explanation for the in vivo preferential fat targeting by DC. Fat tissue, being deficient in cell‐associated proteins and interstitial albumin, may be unable to sufficiently neutralize the detergent activity of DC, possibly making fat uniquely sensitive to DC.
This study was funded by a grant from Kythera. Drs. Bentow and Knopp are consultants for Kythera, and Nadir Mahmood and Nathaniel David are employees of Kythera.</description><subject>Adipocytes - drug effects</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Cell Culture Techniques</subject><subject>Cholagogues and Choleretics - administration & dosage</subject><subject>Cholagogues and Choleretics - pharmacology</subject><subject>Deoxycholic Acid - administration & dosage</subject><subject>Deoxycholic Acid - pharmacology</subject><subject>Dermatology</subject><subject>Fibroblasts - drug effects</subject><subject>Humans</subject><subject>Injections, Subcutaneous</subject><subject>Keratinocytes - drug effects</subject><subject>Medical sciences</subject><subject>Mice</subject><subject>Mice, Obese</subject><subject>Models, Animal</subject><subject>Muscle Cells - drug effects</subject><subject>Muscle, Skeletal - drug effects</subject><subject>Muscle, Skeletal - metabolism</subject><subject>Muscle, Skeletal - pathology</subject><subject>Skin - drug effects</subject><subject>Skin - metabolism</subject><subject>Skin - pathology</subject><subject>Skin plastic surgery</subject><subject>Subcutaneous Fat - drug effects</subject><subject>Subcutaneous Fat - metabolism</subject><subject>Subcutaneous Fat - pathology</subject><subject>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</subject><issn>1076-0512</issn><issn>1524-4725</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNqNkE9PwjAYhxujEUS_gtnFeBr2z9ptBw8GUElIPADnpmvfxi2D4coUbn4EP6OfxA4Qr_bSX94-79v2QSgguE_8uiv6hNMojGLK-xT7KiZciP7mBHWPB6c-41iEmBPaQRfOFRgTmjJ8jjoURwmNKesiNsuda-D782sKJeh1_g7ByFqfXFDZYLwsfAQTDKHabPVrVao1XKIzq0oHV4e9h-aPo9ngOZy8PI0HD5NQszQRIVAFPCKKcZZYSnHKjDZCG2wzk6mMJ9wIprQSYCNueNTWOU5JHPGEYZawHrrdz13V1VsDbi0XudNQlmoJVeNkzFgq_Pe5J5M9qevKuRqsXNX5QtVbSbBsjclCtmJkK0a2xuTOmNz41uvDJU22AHNs_FXkgZsDoJxWpa3VUufuj6MpJtGOu99zH3kJ238_QA6n8zaxH2rHhnQ</recordid><startdate>201006</startdate><enddate>201006</enddate><creator>THUANGTONG, RATTAPON</creator><creator>BENTOW, JASON J.</creator><creator>KNOPP, KRISTEENE</creator><creator>MAHMOOD, NADIR A.</creator><creator>DAVID, NATHANIEL E.</creator><creator>KOLODNEY, MICHAEL S.</creator><general>Blackwell Publishing Inc</general><general>Wiley</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201006</creationdate><title>Tissue‐Selective Effects of Injected Deoxycholate</title><author>THUANGTONG, RATTAPON ; BENTOW, JASON J. ; KNOPP, KRISTEENE ; MAHMOOD, NADIR A. ; DAVID, NATHANIEL E. ; KOLODNEY, MICHAEL S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3986-e2ae541a3538f22093dcd6cd0fbdbab585d63aca6ef45d540fbd5091745830383</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Adipocytes - drug effects</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Cell Culture Techniques</topic><topic>Cholagogues and Choleretics - administration & dosage</topic><topic>Cholagogues and Choleretics - pharmacology</topic><topic>Deoxycholic Acid - administration & dosage</topic><topic>Deoxycholic Acid - pharmacology</topic><topic>Dermatology</topic><topic>Fibroblasts - drug effects</topic><topic>Humans</topic><topic>Injections, Subcutaneous</topic><topic>Keratinocytes - drug effects</topic><topic>Medical sciences</topic><topic>Mice</topic><topic>Mice, Obese</topic><topic>Models, Animal</topic><topic>Muscle Cells - drug effects</topic><topic>Muscle, Skeletal - drug effects</topic><topic>Muscle, Skeletal - metabolism</topic><topic>Muscle, Skeletal - pathology</topic><topic>Skin - drug effects</topic><topic>Skin - metabolism</topic><topic>Skin - pathology</topic><topic>Skin plastic surgery</topic><topic>Subcutaneous Fat - drug effects</topic><topic>Subcutaneous Fat - metabolism</topic><topic>Subcutaneous Fat - pathology</topic><topic>Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>THUANGTONG, RATTAPON</creatorcontrib><creatorcontrib>BENTOW, JASON J.</creatorcontrib><creatorcontrib>KNOPP, KRISTEENE</creatorcontrib><creatorcontrib>MAHMOOD, NADIR A.</creatorcontrib><creatorcontrib>DAVID, NATHANIEL E.</creatorcontrib><creatorcontrib>KOLODNEY, MICHAEL S.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Dermatologic surgery</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>THUANGTONG, RATTAPON</au><au>BENTOW, JASON J.</au><au>KNOPP, KRISTEENE</au><au>MAHMOOD, NADIR A.</au><au>DAVID, NATHANIEL E.</au><au>KOLODNEY, MICHAEL S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Tissue‐Selective Effects of Injected Deoxycholate</atitle><jtitle>Dermatologic surgery</jtitle><addtitle>Dermatol Surg</addtitle><date>2010-06</date><risdate>2010</risdate><volume>36</volume><issue>6</issue><spage>899</spage><epage>908</epage><pages>899-908</pages><issn>1076-0512</issn><eissn>1524-4725</eissn><abstract>BACKGROUND
Recent studies suggest that the principal active ingredient in phosphatidylcholine‐containing injectable fat‐reduction formulations is actually deoxycholate (DC). This bile acid acts as a detergent to rapidly disrupt cell membranes. Thus, it is not obvious why DC would preferentially target fat.
OBJECTIVE
To investigate possible mechanisms for the selectivity of DC for fat tissue using in vivo and in vitro models.
METHODS AND MATERIALS Histology, drug distribution studies, and cell viability assays were used to examine possible mechanisms contributing to DC selectivity.
RESULTS In vitro, DC caused the lysis of all cell types tested within the tested concentration range. DC injected into fat tissue caused adipocyte death, whereas other cell types appeared less affected. Physiological concentrations of albumin or protein‐rich tissues decrease the ability of DC to lyse cells. Furthermore, DC relocated to the gastrointestinal tract in animals within hours of injection. This suggests that similar mechanisms may be present in humans.
CONCLUSION We report observations that provide a possible explanation for the in vivo preferential fat targeting by DC. Fat tissue, being deficient in cell‐associated proteins and interstitial albumin, may be unable to sufficiently neutralize the detergent activity of DC, possibly making fat uniquely sensitive to DC.
This study was funded by a grant from Kythera. Drs. Bentow and Knopp are consultants for Kythera, and Nadir Mahmood and Nathaniel David are employees of Kythera.</abstract><cop>Malden, USA</cop><pub>Blackwell Publishing Inc</pub><pmid>20482723</pmid><doi>10.1111/j.1524-4725.2010.01566.x</doi><tpages>10</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1076-0512 |
ispartof | Dermatologic surgery, 2010-06, Vol.36 (6), p.899-908 |
issn | 1076-0512 1524-4725 |
language | eng |
recordid | cdi_proquest_miscellaneous_733962015 |
source | Wiley Online Library (Online service) |
subjects | Adipocytes - drug effects Animals Biological and medical sciences Cell Culture Techniques Cholagogues and Choleretics - administration & dosage Cholagogues and Choleretics - pharmacology Deoxycholic Acid - administration & dosage Deoxycholic Acid - pharmacology Dermatology Fibroblasts - drug effects Humans Injections, Subcutaneous Keratinocytes - drug effects Medical sciences Mice Mice, Obese Models, Animal Muscle Cells - drug effects Muscle, Skeletal - drug effects Muscle, Skeletal - metabolism Muscle, Skeletal - pathology Skin - drug effects Skin - metabolism Skin - pathology Skin plastic surgery Subcutaneous Fat - drug effects Subcutaneous Fat - metabolism Subcutaneous Fat - pathology Surgery (general aspects). Transplantations, organ and tissue grafts. Graft diseases |
title | Tissue‐Selective Effects of Injected Deoxycholate |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T15%3A18%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Tissue%E2%80%90Selective%20Effects%20of%20Injected%20Deoxycholate&rft.jtitle=Dermatologic%20surgery&rft.au=THUANGTONG,%20RATTAPON&rft.date=2010-06&rft.volume=36&rft.issue=6&rft.spage=899&rft.epage=908&rft.pages=899-908&rft.issn=1076-0512&rft.eissn=1524-4725&rft_id=info:doi/10.1111/j.1524-4725.2010.01566.x&rft_dat=%3Cproquest_cross%3E733962015%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3986-e2ae541a3538f22093dcd6cd0fbdbab585d63aca6ef45d540fbd5091745830383%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=733962015&rft_id=info:pmid/20482723&rfr_iscdi=true |